Abstract

PreScription: Endemics, Epidemics, and Pandemics

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4

View All Articles in Issue

Page(s): 268

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2021 Pg. 268	PreScription: Endemics, Epidemics, and Pandemics Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 287-295	Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Author(s): McElhiney Linda F
Jan/Feb 2023 Pg. 12-21	Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants Author(s): Riepl Mike
Jul/Aug 2020 Pg. 268	PreScription: COVID-19 and Compounding Pharmacists Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 98-107	Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment Author(s): Riepl Mike
Sep/Oct 2023 Pg. 368-380	Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment Author(s): Riepl Mike, Kaiser Joe
Jul/Aug 2023 Pg. 284-293	Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID Author(s): Riepl Mike, Kaiser Joe
Sep/Oct 2020 Pg. 358-364	Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Author(s): Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Mar/Apr 2021 Pg. 109-113	Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Author(s): Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
May/Jun 2023 Pg. 192-200	Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Author(s): Riepl Mike, Kaiser Joe
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Nov/Dec 2011 Pg. 450-457	Compounding for Treatment of Equine Infectious Diseases: An Overview Author(s): Bramwell Bethany L
Jul/Aug 2020 Pg. 316	Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 296-297	A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Author(s): Brunner Scott
Sep/Oct 2021 Pg. 386-387	It's Time for a New Philosophy Author(s): Brunner Scott
Jul/Aug 2020 Pg. 310	Calculations Author(s): Stockton Shelly J
Mar/Apr 2022 Pg. 100-109	Allowing Compounding Pharmacies to Address Drug Shortages Author(s): Broughel James
Nov/Dec 2003 Pg. 458-459	Technology Spotlight: Automated Prescription-Dispensing Systems Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn